Miltenyi Biotec

Diffuse large B-cell lymphoma
#Advanced Therapies #Cancer research #CAR T-cell therapy #Lymphoma #Miltenyi Biotec

CAR-T therapy could treat large B-cell lymphoma 

Biotechnology company Miltenyi Biotec has announced encouraging results from its CAR-T therapy for patients with second-line, relapsed or refractory large B-cell lymphoma.  Primary analysis of candidate zamtocabtagene autoleucel (zamto-cel) showed the therapy demonstrated significant and clinically meaningful superiority over chemoimmunotherapy. The candidate was evaluated in the DALY 2-EU trial, conducted… Read More

#Cancer Research #News

#Drug development #Drug discovery #Flow Cytometry #Miltenyi Biotec #Narrated podcasts

Flow Cytometry in Drug Discovery

This narrated article is called “Why flow cytometry in drug discovery is a real life-saver”, in which Roy, Global Product Manager at Miltenyi Biotec, outlines the benefits of flow cytometry, offering case study examples for its use. Capable of boasting high-throughput, accurate, multiparameter and highly reproducible results, it’s time for… Read More

#Podcasts